Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1927 1
1946 1
1949 1
1950 7
1951 3
1952 1
1953 2
1954 2
1955 5
1956 10
1957 7
1958 7
1959 1
1960 5
1962 1
1963 1
1964 8
1965 6
1966 3
1967 5
1968 5
1969 6
1970 6
1971 3
1972 6
1973 7
1974 10
1975 14
1976 11
1977 19
1978 30
1979 33
1980 39
1981 63
1982 68
1983 78
1984 98
1985 138
1986 154
1987 164
1988 197
1989 218
1990 246
1991 290
1992 335
1993 367
1994 396
1995 438
1996 512
1997 555
1998 588
1999 659
2000 798
2001 884
2002 878
2003 1063
2004 1292
2005 1278
2006 1383
2007 1501
2008 1642
2009 1735
2010 1927
2011 2090
2012 2247
2013 2336
2014 2453
2015 2622
2016 2775
2017 2883
2018 3074
2019 3217
2020 3481
2021 3506
2022 3367
2023 3526
2024 3743
2025 3140
2026 6

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

58,985 results

Results by year

Filters applied: . Clear all
Page 1
Antibody-drug conjugates: Recent advances in linker chemistry.
Su Z, Xiao D, Xie F, Liu L, Wang Y, Fan S, Zhou X, Li S. Su Z, et al. Acta Pharm Sin B. 2021 Dec;11(12):3889-3907. doi: 10.1016/j.apsb.2021.03.042. Epub 2021 Apr 6. Acta Pharm Sin B. 2021. PMID: 35024314 Free PMC article. Review.
The pursuit of ADCs with optimal therapeutic windows has resulted in remarkable progress in the discovery and development of novel linkers. The present review summarizes the advance of the chemical trigger, linker-antibody attachment and linker-payload attach …
The pursuit of ADCs with optimal therapeutic windows has resulted in remarkable progress in the discovery and development of novel linker …
Cleavable linkers in antibody-drug conjugates.
Bargh JD , Isidro-Llobet A , Parker JS , Spring DR . Bargh JD , et al. Chem Soc Rev. 2019 Aug 12;48(16):4361-4374. doi: 10.1039/c8cs00676h. Chem Soc Rev. 2019. PMID: 31294429 Review.
Although ADC linkers can be 'non-cleavable', the vast majority of ADCs in clinical development have specific release mechanisms to allow controlled linker cleavage at the target site and are thus termed 'cleavable'. ...This review summarises the advances in the fiel …
Although ADC linkers can be 'non-cleavable', the vast majority of ADCs in clinical development have specific release mechanisms to al …
Calmodulin's Interdomain Linker Is Optimized for Dynamics Signal Transmission and Calcium Binding.
Sun B, Kekenes-Huskey PM. Sun B, et al. J Chem Inf Model. 2022 Sep 12;62(17):4210-4221. doi: 10.1021/acs.jcim.2c00587. Epub 2022 Aug 22. J Chem Inf Model. 2022. PMID: 35994621
However, a molecular picture of how amino acid differences in the linker influence protein function is still lacking. By using extensive Gaussian-accelerated MD coupled with dynamic network analysis, we reveal the molecular bases underlying the linker's role …
However, a molecular picture of how amino acid differences in the linker influence protein function is still lacking. By using extens …
Lysosomal-Cleavable Peptide Linkers in Antibody-Drug Conjugates.
Balamkundu S, Liu CF. Balamkundu S, et al. Biomedicines. 2023 Nov 16;11(11):3080. doi: 10.3390/biomedicines11113080. Biomedicines. 2023. PMID: 38002080 Free PMC article. Review.
In addition to cathepsin-cleavable linkers, there is also growing interest in legumain-sensitive linkers for ADC development. Increasing plasma stability while maintaining lysosomal cleavability of ADC linkers is an objective of intensive current research. Th …
In addition to cathepsin-cleavable linkers, there is also growing interest in legumain-sensitive linkers for ADC development. …
Exploring linker's sequence diversity to fuse carotene cyclase and hydroxylase for zeaxanthin biosynthesis.
Bouin A, Zhang C, Lindley ND, Truan G, Lautier T. Bouin A, et al. Metab Eng Commun. 2023 Apr 24;16:e00222. doi: 10.1016/j.mec.2023.e00222. eCollection 2023 Jun. Metab Eng Commun. 2023. PMID: 37168436 Free PMC article.
However, the design of a protein fusion and the choice of a linker are often challenging and lack of guidance. To determine the impact of linker parameters on fusion proteins, a library of linkers featuring various lengths, secondary structures, extensions an …
However, the design of a protein fusion and the choice of a linker are often challenging and lack of guidance. To determine the impac …
Assessing the Role of Calmodulin's Linker Flexibility in Target Binding.
Sun B, Kekenes-Huskey PM. Sun B, et al. Int J Mol Sci. 2021 May 8;22(9):4990. doi: 10.3390/ijms22094990. Int J Mol Sci. 2021. PMID: 34066691 Free PMC article.
Its binding selectivity to many of these targets is partially attributed to the protein's flexible alpha helical linker that connects its N- and C-domains. It is not well established how its linker mediates CaM's binding to regulatory targets yet. ...This effect app …
Its binding selectivity to many of these targets is partially attributed to the protein's flexible alpha helical linker that connects …
Linkers: An Assurance for Controlled Delivery of Antibody-Drug Conjugate.
Sheyi R, de la Torre BG, Albericio F. Sheyi R, et al. Pharmaceutics. 2022 Feb 11;14(2):396. doi: 10.3390/pharmaceutics14020396. Pharmaceutics. 2022. PMID: 35214128 Free PMC article. Review.
ADCs consist of recombinant monoclonal antibodies that are covalently bound to cytotoxic chemicals via synthetic linkers. The linker has a key role in ADC outcomes because its characteristics substantially impact the therapeutic index efficacy and pharmacokinetics o …
ADCs consist of recombinant monoclonal antibodies that are covalently bound to cytotoxic chemicals via synthetic linkers. The link …
Design of helical linkers for fusion proteins and protein-based nanostructures.
Arai R. Arai R. Methods Enzymol. 2021;647:209-230. doi: 10.1016/bs.mie.2020.10.003. Epub 2020 Nov 18. Methods Enzymol. 2021. PMID: 33482989 Review.
Fusion proteins are constructed by the linking of two protein domains with a peptide linker. The selection of a linker sequence is important for the construction of stable and bioactive fusion proteins. Empirically designed linkers are generally classified in …
Fusion proteins are constructed by the linking of two protein domains with a peptide linker. The selection of a linker sequenc …
Current strategies for the design of PROTAC linkers: a critical review.
Troup RI, Fallan C, Baud MGJ. Troup RI, et al. Explor Target Antitumor Ther. 2020;1(5):273-312. doi: 10.37349/etat.2020.00018. Epub 2020 Oct 30. Explor Target Antitumor Ther. 2020. PMID: 36046485 Free PMC article. Review.
While linker design has historically received limited attention, the PROTAC field is evolving rapidly and currently undergoing an important shift from synthetically tractable alkyl and polyethylene glycol to more sophisticated functional linkers. ...The authors high …
While linker design has historically received limited attention, the PROTAC field is evolving rapidly and currently undergoing an imp …
58,985 results
You have reached the last available page of results. Please see the User Guide for more information.